Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.59 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.59 |
| ▸ | TYMP | P19971 | 1/20 | 0.53 |
| ▸ | NT5E | P21589 | 2/20 | 0.51 |
| ▸ | HINT1 | P49773 | 1/20 | 0.51 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | POLA1 | P09884 | 1/20 | 0.48 |
| ▸ | GSK3A | P49840 | 2/20 | 0.48 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.48 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8490891 | 0.92 | POLB (0.71) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL15798769 | 0.91 | POLB (0.70) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL16359949 | 0.91 | POLB (0.70) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL15012843 | 0.91 | POLB (0.70) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL338650 | 0.91 | POLB (0.70) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL20266299 | 0.90 | POLB (0.72) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL25171429 | 0.89 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL3744960 | 0.89 | POLB (0.68) | POLBP2RY2P2RY4P2RY6TYMP | |
| SCHEMBL48232 | 0.89 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL22054664 | 0.89 | POLB (0.68) | POLBP2RY2P2RY4P2RY6TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020197905-A1 | USE OF INOSINE FOR CANCER IMMUNOTHERAPY | IMMUNOSPARKLE BIOSCIENCE LLC (US) | 2020-10-01 | — | — | WO | claimed |
| US-10736913-B1 | Use of inosine for cancer immunotherapy | IMMUNOSPARKLE BIOSCIENCE LLC (US) | 2020-08-11 | — | — | US | claimed |
| EP-3111800-B1 | DEVICE FOR IDENTIFYING ORAL CONDITIONS | COLGATE PALMOLIVE CO (US) | 2018-11-21 | — | — | EP | claimed |
| CN-104970898-B | For identifying the device of oral conditions | 高露洁-棕榄公司 | 2018-05-29 | — | — | CN | claimed |
| US-9700395-B2 | Device for identifying oral conditions | COLGATE-PALMOLIVE COMPANY (US) | 2017-07-11 | — | — | US | claimed |
| EP-3111800-A1 | DEVICE FOR IDENTIFYING ORAL CONDITIONS | Colgate-Palmolive Company (US) | 2017-01-04 | — | — | EP | claimed |
| CN-104970898-A | DEVICE FOR IDENTIFYING ORAL CONDITIONS | COLGATE PALMOLIVE CO | 2015-10-14 | — | — | CN | claimed |
| US-20150072301-A1 | DEVICE FOR IDENTIFYING ORAL CONDITIONS | COLGATE PALMOLIVE CO (US) | 2015-03-12 | — | — | US | claimed |
| US-20120322023-A1 | DEVICE FOR IDENTIFYING ORAL CONDITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2012-12-20 | — | — | US | claimed |
| CN-102655788-A | Device for identifying oral conditions | COLGATE PALMOLIVE CO | 2012-09-05 | — | — | CN | claimed |
| EP-0845732-A2 | Method for assessing oxidative stress and its control in humans | Nikken Foods Company Limited (JP) | 1998-06-03 | — | — | EP | claimed |
| US-12622640-B2 | Oral data collecting device for diagnosis or prognosis | Emanate Biomedical, Inc. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260071179-A1 | PRODUCTION METHOD OF NERVE CELLS DAMAGED BY OXIDATIVE STRESS AND APPLICATIONS THEREOF | FUJIFILM CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-4682249-A1 | METHOD FOR PRODUCING NERVE CELLS DAMAGED BY OXIDATION STRESS AND APPLICATION THEREOF | FUJIFILM Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024190850-A1 | METHOD FOR PRODUCING NERVE CELLS DAMAGED BY OXIDATION STRESS AND APPLICATION THEREOF | 富士フイルム株式会社 | 2024-09-19 | — | — | WO | disclosed |
| US-6133306-A | Methods of inhibiting neurodegerative diseases | THE GENERAL HOSPITAL CORPORATION (US) | 2000-10-17 | — | — | US | disclosed |
| US-5950634-A | PREPARING A CHART FOR ASSESSING OXIDATIVE STRESS WHEREIN NUMERICAL FIGURE REPRESENTING THE DEGREE OF EXCESS OR DEFICIENCY OF AN INDICATOR SUBSTANCE INDICATING OXIDATIVE STRESS IN HUMANS | NIKKEN FOODS CO., LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| US-5849782-A | Methods of inhibiting neurodegenerative diseases | THE GENERAL HOSPITAL CORPORATION (US) | 1998-12-15 | — | — | US | disclosed |
| EP-0845732-A2 | Method for assessing oxidative stress and its control in humans | Nikken Foods Company Limited (JP) | 1998-06-03 | — | — | EP | disclosed |
| WO-1996021445-A1 | METHODS OF INHIBITING NEURODEGENERATIVE DISEASES | THE GENERAL HOSPITAL CORPORATION (US) | 1996-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10736913-B1 | Use of inosine for cancer immunotherapy | CD47, ICOS, HAVCR2 | POLB 4423/4885P2RY2 574/4885P2RY4 1457/4885 |
| US-12622640-B2 | Oral data collecting device for diagnosis or prognosis | TAS2R30, TAS2R39, TAS2R46 | POLB 3435/4885P2RY2 1064/4885P2RY4 1543/4885 |
| US-20260071179-A1 | PRODUCTION METHOD OF NERVE CELLS DAMAGED BY OXIDATIVE STRESS AND APPLICATIONS THEREOF | AIFM2, AIFM1, FECH | POLB 1638/4885P2RY2 1305/4885P2RY4 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.